Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950103-25-008153
Filing Date
2025-06-30
Accepted
2025-06-30 17:28:28
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dp230854_s3.htm S-3 386231
2 EXHIBIT 5.1 dp230854_ex0501.htm EX-5.1 49409
3 EXHIBIT 23.1 dp230854_ex2301.htm EX-23.1 5124
4 EXHIBIT 107 dp230854_exfilingfees.htm EX-FILING FEES 22317
5 GRAPHIC image_003.jpg GRAPHIC 4159
6 GRAPHIC image_004.jpg GRAPHIC 4161
7 GRAPHIC image_005.jpg GRAPHIC 1307
8 GRAPHIC image_006.jpg GRAPHIC 1307
9 GRAPHIC image_008.jpg GRAPHIC 2593
  Complete submission text file 0000950103-25-008153.txt   483436
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288437 | Film No.: 251093387
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)